Regulatory subunit type I-α of protein kinase A (PRKARIA): A tumor-suppressor gene for sporadic thyroid cancer

Genes Chromosomes and Cancer

Volumn 35, Issue 2, 2002, Pages 182-192

  Sandrini, Fabiano ^a   Matyakhina, Ludmila ^a,b   Sarlis, Nicholas J ^c   Kirschner, Lawrence S ^a   Farmakidis, Constantine ^a   Gimm, Oliver ^d   Stratakis, Constantine A ^a,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC NUCLEOTIDE;

ALLELE; ARTICLE; CARCINOGENESIS; CARNEY COMPLEX; CHROMOSOME 17Q; CHROMOSOME LOSS; CHROMOSOME MAP; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; THYROID CANCER; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0036778647     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10112     Document Type: Article

References (59)

1. Papillary thyroid carcinoma. Etiology, assessment, and therapy
2. A refractory phase in cyclic AMP-responsive transcription requires down regulation of protein kinase A
3. Multiple cutaneous myxomas coinciding with repeated cardiac myxomas. A syndrome
4. Papillary thyroid carcinoma (PTC) in a child with McCune Albright syndrome: More than random association?
5. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A
6. The hamartoma-adenoma-carcinoma sequence
7. The 3',5′-cyclic adenosine monophosphate response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas
8. Primay pigmented nodular adrenocortical disease and its associated conditions
9. Extracellular protein kinase A as a cancer biomarker: Its expression by tumor cells and reversal by a myristate-lacking C alpha and RII beta subunit overexpression
10. Antisense DNAs as multisite genomic modulators identified bv DNA microarray
11. Clear-cell carcinoma in a patient with McCune-Albright syndrome: Clinical description and analysis of tumor features
12. Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene
13. The cyclic AMP-mediated stimulation of cell proliferation
14. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation
15. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas
16. Familial papillary thyroid cancer-many syndromes, too many genes
17. G protein and thyrotropin receptor mutations in thyroid neoplasia
18. Mutation analysis of protein kinase A catalytic subunit in thyroid adenomas and pituitary tumours
19. Familial nonmedullary thyroid carcinoma - The case for genetic susceptibility
20. Genetics of follicular thyroid cancer
21. Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells
22. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules
23. Somatic mutation and germline variants of MINPP1, a phospharase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas
24. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
25. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors
26. Different growth control of the two human thyroid cell lines of adenomatous goiter and papillary carcinoma
27. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analvsis
28. Lessons from hereditary colorectal cancer
29. Large-scale preparation of sequence-ready bacterial artificial chromosome DNA using QIAGEN columns
30. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex
31. Genetic heterogeneity and spectrum of mutations of the PRKARIA gene in patients with the Carney complex
32. Allelotyping of anaplastic thyroid carcinoma: Frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q
33. Chasing the cancer demon
34. Cyclic nucleotide-dependent protein kinases. V. Preparation and properties of adenosine 3′,5′-monophosphate-dependent protein kinase from various bovine tissues
35. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas
36. Costimulation of adenylyl cyclase and phospholipase C by a mutant alpha 1B-adrenergic receptor transgene promotes malignant transformation of thyroid follicular cells
37. Phosphorylation of centrin during the cell cycle and its role in centriole separation preceding centrosome duplication
38. Activation of the cyclic AMP cascade as an oncogenic mechanism: The thyroid example
39. Management of a solitary thyroid nodule
40. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection
41. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex)
42. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
43. Carney complex: Report of three cases
44. Mitogenic effects of thyrotropin and adenosine 3′,5′-monophosphate in differentiated normal human thyroid cells in vitro
45. Activating mutations of the TSH receptor in differentiated thyroid carcinomas
46. Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: Basic aspects
47. Cyclic nucleotide-dependent protein kinases
48. A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma
49. Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes
50. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2
51. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex)
52. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex)
53. Carney complex: Diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas
54. Ovarian lesions in Carney complex: Clinical genetics and possible predisposition to malignancy
55. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues
56. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas
57. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors
58. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation